Soligenix, Emergent team up on ricin poisoning vaccine; Liberia declared Ebola-free;

> Soligenix and Emergent BioSolutions ($EBS) announced a development partnership for a ricin poisoning vaccine. Release

> As the Ebola outbreak came to a close in Liberia this week, the country commenced its campaigns for polio and measles immunizations. More

> A Cuban lung cancer vaccine has gained approval to come to the U.S. in its first step to a possible FDA approval. Story

> VaxInnate announced the promotion of Lynda Tussey to CSO and Bruce Weaver to vice president of manufacturing, as well as the hiring of Peter Fusco, who will serve as R&D vice president, and Stephen Haworth, who will serve as vice president of clinical. Release

> New research shows that Gardasil-9 can prevent more than 80% of cervical cancers. More

> In India, an H1N1 epidemic has led to a three-fold increase in flu vaccinations. Story

And Finally... The Canadian government celebrated the birth of the royal baby with a $100,000 donation to pro-vaccine group Immunize Canada. More

Suggested Articles

Ebola has claimed thousands of lives in recent outbreaks, but now the world has a licensed vaccine option in Merck's Ervebo.

Cosette Pharmaceuticals which was formed in December with a deal for dermatology projects has gone back to G&W Labs for a liquids plant.

Takeda has spent considerable resources on its phase 3 dengue vaccine, and now data show the shot was 80% effective in preventing dengue.